Paediatric HIV encephalopathy in sub-Saharan Africa

Physical Therapy Reviews

Volumn 15, Issue 5, 2010, Pages 410-417

  Hilburn, Nicole ^a   Potterton, Joanne ^a   Stewart, Aimee ^a  

^a UNIVERSITY OF THE WITWATERSRAND   (South Africa)

Author keywords

ENCEPHALOPATHY; HIV AIDS; NEURODEVELOPMENT; PAEDIATRIC; SUB SAHARAN AFRICA

Indexed keywords

EID: 85014119617     PISSN: 10833196     EISSN: 1743288X     Source Type: Journal    
DOI: 10.1179/1743288X10Y.0000000013     Document Type: Review

References (89)

1. UNAIDS AIDS Epidemic Update 2009. [cited 2010 Feb]. Available from: http://www.unaids.org
2. Dabis F, Ekpini E. HIV-1/AIDS and maternal and child health in Africa. Lancet 2009;359:2097–104.
3. Rausch D, Stover E. Neuroscience research in AIDS. Prog Neuropsychopharmacol Biol Psychiatry 2001;25:231–57.4 Belman A. Acquired immunodeficiency syndrome and the child’s central nervous system. Pediatr Clin North Am 1992;39(4):691–713.
4. Luzuriaga K, Sullivan J. Pediatric HIV-1 infection: advances and remaining challenges. AIDS Rev 2002;4:21–6.
5. European Collaborative Study. Vertical transmission of HIV-1: maternal immune status and obstetric factors. AIDS 1996;10:1675–81.
6. Chouquet C, Richardson S, Burgard M, Blanche S, Mayaux M, Rouzioux C, et al. Timing of human immunodeficiency virus type 1 (HIV-1) transmission from mother to child: Bayesian estimation using a mixture. Stat Med 1999;18:815–33.
7. Newell, M. Mechanisms and timing of mother-to-child transmission of HIV-1. AIDS 1998;12:831–7.
8. European Collaborative Study. Maternal viral load and vertical transmission of HIV-1: an important factor but not the only one. AIDS 1999;13:1377–85.
9. Willen E. Neurocognitive outcomes in pediatric HIV. Ment Retard Dev Disabil Res Rev 2006;12:223–8.
10. Coutsoudis A, Dabis F, Fawzi W, Gaillard P, Haverkamp G, Harris D, et al. Late postnatal transmission of HIV-1 in breastfed children: an individual patient data meta-analysis. J Infect Dis 2004;189:2154–66.
11. Nduati R, Mbori-Ngacha D, Richardson B, Panteleeff D, Mwatha A, Overbaugh J, et al. Correlates of mother-to-child human immunodeficiency virus type 1 (HIV-1) transmission: association with maternal plasma HIV-1 RNA load, genital HIV-1 DNA shedding, and breast infections. J Infect Dis 2001;183:206–12.
12. Coovadia H, Bland R. Preserving breastfeeding practice through the HIV pandemic. Trop Med Int Health 2007;12:1116–33.
13. Potterton J, Stewart A, Cooper P, Becker P. The effect of a home stimulation programme on the development of young children infected with HIV. Dev Med Child Neurol 2010;52(6):547–51.
14. Potterton J, Stewart A, Cooper P, Baillieu N, Gajdosik C. Neurodevelopmental delay in children infected with HIV in Soweto, South Africa. Vulnerable Child Youth Stud 2009;4(1):48–57.
15. Baillieu N, Potterton J. The extent of delay of language, motor and cognitive development in HIV positive infants. J Neurol Phys Ther 2008;32 (3):118–21.
16. Raskino C, Pearson D, Baker C, Lifschitz M, O’Donnell T, Nozyce M, et al. Neurologic, neurocognitive and brain growth outcomes in human immuno-deficiency virus-infected children receiving different nucleoside antiretroviral regimens. Pediatrics 1999;104:e32.
17. Nozyce M, Hitteman J, Muenz L, Durako C, Fischer M, Willoughby A. Effect of perinatally acquired human immunodeficiency virus infection on neurodevelopment in children during the first two years of life. Pediatrics 1994;94(6):883–91.
18. Tardieu M, Le Chenadec M, Persoz A, Meyer L, Blanche S, Mayaux M. HIV-1 related encephalopathy in infants compared with children and adults. Neurology 2000;54:1089–95.
19. Gabuzda D, Hirsch M. Neurologic manifestations of infection with human immunodeficiency virus: clinical features and pathogenesis. Ann Intern Med 1986;107:383–91.
20. Tardieu M, Hery C, Peudenier S, Boespflug O, Montagnier L. Human immunodeficiency virus type-1-infected monocytic cells can destroy human neural cells after cell-to-cell adhesion. Ann Neurol 1992;32:11–7.
21. Ioannidis J, Tatsioni A, Abrams J. Maternal viral load and rate of disease progression among vertically HIV-1-infected children: an international meta-analysis. AIDS 2004;18:99–108.
22. Williams A, Duong T, McNally L. Pneumocystis carinii pneumonia and cytomegalovirus infection in children with vertically acquired HIV infection. AIDS 2001;15:335–9.
23. Fowler M. Paediatric HIV infection: neurologic and neuropsychological findings. Acta Paediatr Supp 1994;400:59–62.
24. Belman A. AIDS and pediatric neurology. Neurol Clin 1990;8(3):571–603.
25. Bissiachi P, Suppiej A, Laverda A. Neuropsychological evaluation of neurologically asymptomatic HIV-infected children. Brain Cogn 2000;43:49–52.
26. Blanchette N, Smith M, Fernandes-Penney A, King S, Read S. Cognitive and motor development in children with vertically transmitted HIV infection. Brain Cogn 2001;46:46–9.
27. Chase C, Ware J, Hittelman J, Blasini I, Smith R, Llorente A, et al. Early cognitive and motor development amongst infants born to women infected with human immunodeficiency virus. Pediatrics 2000;106(2):e25.
28. Udgirkar V, Tullu M, Bavdekar S, Shaharao V, Kamat J, Hira P. Neurological manifestations of HIV infection. Indian Pediatr 2003;40:230–4.
29. Epstein L, Sharer L, Oleske J, Connor E, Goudsmit J, Bagdon L, et al. Neurologic manifestations of human immunodeficiency virus infection in children. Pediatrics 1986;78:678–87.
30. Pearson D, McGrath N, Nozyce M, Nichols S, Raskino C, Brouwers P, et al. Predicting HIV disease progression in children using measures ofneuropsychological and neurological functioning. Pediatrics 2000;106:e76.
31. Fragoso Y, Andalat R, Adamo A, Lopes de Fonseca N, Moryiama M. Neurologic manifestations of AIDS in children and adolescents: a review of cases in Santos, Brazil. MedGenMed 1999;24:E3.
32. Drotar D, Olness K, Wizniter M, Guay L, Marum L, Svilar G, et al. Neurodevelopmental outcomes of Ugandan infants with human immunodeficiency virus type 1 infection. Pediatrics 1997;100(1):e5.
33. Wolters P, Brouwers P, Civitello L, Moss H. Receptive and expressive language function ofchildren with symptomatic HIV infection and relationship with disease parameters: a longitudinal 24-month follow-up study. AIDS 1997;11:1135–44.
34. Wolters P, Brouwers P, Moss H, Pizzo P. Differential receptive and expressive language functioning of children with symptomatic HIV disease and relation to CT brain abnormalities. Pediatrics 1995;95(1):112–9.
35. Tornatore C, Chandra R, Berger J, Major E. HIV-1 infection of subcortical astrocytes in the pediatric central nervous system. Neurology 1994;44:481–7.
36. Ellis R, Calero P, Stockin M. HIV infection and the central nervous system: a primer. Neuropsychol Rev 2009;19:144–51.
37. Epstein L, Gendelman H. Human immunodeficiency virus type 1 infection of the nervous system: pathogenetic mechanisms. Ann Neur 1993;33:429–36.
38. Belman A, Diamond G, Dickson D, Horoupian D, Llena J, Lantos G, et al. Pediatric acquired immunodeficiency syndrome: neurologic syndromes. Am J Dis Child 1988;142:29–35.
39. Brady M, McGrath N, Brouwers P, Gelber R, Glenn-Fowler M, Yogev R, et al. Randomized study of the tolerance and efficacy ofhigh-versus-low dose zidovudine in human immunodeficiency virus-infected children with mild to moderate symptoms. J Infect Dis 1995;173:1097–106.
40. World Health Organisation. WHO case definitions for surveillance of HIV and revised clinical staging and immunological classification of HIV-related disease in adults and children. 2007. [cited 2010 Feb]. Available from: http://www.who.int.
41. Tindyebwa D, Kayita J, Musoke P, Eley B, Nduati R, Coovadia H, et al. Handbook on paediatric AIDS in Africa by the African network for the care of children affected by AIDS. 2004. [cited 2009 Jul]. Available from: http://www.rcqhc.org.
42. Belman A, 1994 HIV-1 associated CNS disease in infants and children. In: Price RW, Perry SW, editors. HIV, AIDS and the brain. New York: Raven Press; 1994. p. 289–310.
43. Simpson DM, Berger JR. Neurologic manifestations of HIV infection. Med Clin North Am 1996;80(6):1363–94.
44. Armstrong F, Seidel J, Swales T. Pediatric HIV infection: a neuropsychological and educational challenge. J Learn Disabil 1993;26:92–103.
45. Brouwers P, DeCarli C, Civatello L, Moss H, Wolters P, Pizzo P. Correlations between CT-brain scan abnormalities and neuropsychological function in children with symptomatic HIV disease. Arch Neurol 1995;52:39–44.
46. Ultmann M, Belman A, Ruff H. Developmental abnormalities in infants and children with acquired immune deficiency syndrome (AIDS) and AIDS-related complex. Dev Med Child Neurol 1985;27:563–71.
47. McGrath N, Fawzi W, Bellinger D, Robins J, Msamanga G, Manjii K, et al. The timing of mother-to-child transmission of human immunodeficiency virus infection and the neurodevelopment of children in Tanzania. Pediatr Infect Dis J 2006;25:47–52.
48. Ferguson G, Jelsma J. The prevalence of motor delay among HIV infected children living in Cape Town, South Africa. Int J Rehabil Res 2009;32:108–14.
49. van Rie A, Dow A, Mapula A, Stewart P. Neurodevelopmental trajectory of HIV-infected children accessing care in Kinshasa, Democratic Republic of the Congo. J Acquir Immune Defic Syndr 2009;52(5):636–42.
50. Msellati P, Lepage P, Hihama D, van Goetham C, van de Perre P, Dabis F. Neurodevelopmental testing ofchildren born to human immunodeficiency virus type 1 seropositive and seronegative mothers: a prospective cohort in Kigali, Rwanda. Pediatrics 1993;92(6):843–8.
51. van Rie A, Mupuala A, Dow A. Impact of the HIV/AIDS epidemic on the neurodevelopment of preschool-aged children in Kinshasa, Democratic Republic of the Congo. Pediatrics 2008;122(1):e123–8.
52. Robertson K, Kopnisky K, Hakim J, Merry C, Nakasujja N, Hall C, et al. Second assessment of neuroAIDS in Africa. J Neurovirol 2008;14:89–101.
53. Newell M, Coovadia H, Cortina-Borja M, Rollins N, Gaillard P, Dabis F, et al. Mortality ofinfected and uninfected infants born to HIV-infected mothers in Africa: a pooled analysis. Lancet 2004;364:1236–43.
54. Taha T, Graham S, Kumwenda N, Broadhead R, Hoover D, Markarkis D, et al. Morbidity among human immunodeficiency virus-1-infected and uninfected African children. Pediatrics 2000;106(6):e77.
55. Laufer M, Scott G. Medical management of HIV disease in children. Pediatr Clin North Am 2000;47(1):127–53.
56. Belman A, Muenz L, Marcus J, Goedert J, Landesman S, Rubinstein A, et al. Neurologic status of human immunodeficiency virus-1 infected infants and their controls: a prospective study from birth to 2 years. Pediatrics 1996;98(6):1109–18.
57. Blanche S, Tardieu M, Duliege A, Rouzioux C, Le Diest F, Fukunaga K, et al. Longitudinal study of 94 symptomatic infants with perinatally acquired human immunodeficiency virus infection. Am J Dis Child 1990;144:1210–5.
58. Cooper S, Lyall H, Walters S, Tudor-Williams G, Habibi G, de Munter C, et al. Children with human immunodeficiency virus admitted to a paediatric intensive care unit in the United Kingdom over a 10-year period. Intensive Care Med 2004;30(1):113–8.
59. Marcotte T, Deutsch R, McCutchan J, Moore D, Letendre S, Ellis R, et al. Prediction of incident neurocognitive impairment by plasma HIV RNA and CD4 levels early after HIV seroconversion. Arch Neurol 2003;60:1406–12.
60. Mekmullica J, Brouwers P, Charurat M, Paul M, Shearer W, Mendez H, et al. Early immunological predictors of neurode-velopmental outcomes in HIV-infected children. Clin Infect Dis 2009;48:338–46.
61. Arpadi S. Growth failure in children with HIV infection. J Acquir Immune Defic Syndr 2000;25:S37–42.
62. Meyers T, Pettifor J, Gray G, Crewe-Brown H, Galpin J. Pediatric admissions with human immunodeficiency virus infection at a regional hospital in Soweto, South Africa. J Trop Pediatr 2000;46(4):224–30.
63. Peckham C, Gibb D. Mother-to-child transmission of human immunodeficiency virus. N Engl J Med 1995;333:298–303.
64. Smith R, Malee K, Charurat Magder L, Mellins C, Macmillan C, Hittleman J, et al. Timing ofperinatal human immunodeficiency virus type 1 infection and rate of neurodevelopment. Pediatr Infect Dis J 2000;19(9):862–71.
65. Davis L, Hjelle B, Miller V, Palmer D, Llewellyn A, Merlin T, et al. Early viral brain invasion in iatrogenic human immunodeficiency virus infection. Neurology 1992;42:1736–9.
66. Gendelman H, Lipton S, Tardieu M, Bukrinsky M, Nottet H. The neuropathogenesis of HIV-1 infection. J Leukoc Biol 1994;56:389–98.
67. Coplan J, Contello K, Cunningham C, Weiner L, Dye T, Roberge L, et al. Early language development in children exposed to or infected with human immunodeficiency virus. Pediatrics 1998;102:8–14.
68. Jeremy R, Kim S, Nozyce M, Nachman S, McIntosh K, Pelton S, et al. Neuropsychological functioning and viral load in stable antiretroviral therapy-experienced HIV-infected children. Pediatrics 2005;115:380–7.
69. Brackis-Cott E, Kang E, Dolezal C, Abrams E, Mellins C. Brief report: language ability and school functioning of youth perinatally infected with HIV. J Pediatr Health Care 2009;23(3):158–64.
70. Martin S, Wolters P, Toledo-Tamula M, Zeichner S, Hazra R, Civitello L. Cognitive functioning in school-aged children with vertically acquired HIV infection being treated with highly active antiretroviral therapy (HAART). Dev Neuropsychol 2006;30:633–57.
71. Smith R, Malee K, Leighty R, Brouwers P, Mellins C, Hittelman J, et al. Effects of perinatal HIV infection and associated risk factors on cognitive development among young children. Pediatrics 2006;117:851–62.
72. van Rie A, Harrington P, Dow A, Robertson K. Neurologic and neurodevelopmental manifestations of pediatric HIV/AIDS: a global perspective. Eur J Paediatr Neurol 2007;11:1–9.
73. Jin X, Sun Y, Jiang F, Ma J, Morgan C, Shen X. ‘Care for Development’ intervention in rural China: a prospective follow-up study. J Dev Behav Pediatr 2007;28:213–8.
74. Bridge A, Kipp W, Jhangri GS, Laing L, Konde-Lule J. Nutritional status of young children in AIDS-affected households and controls in Uganda. Am J Trop Med Hyg 2006;74:926–31.
75. Abubakar A, van Baar A, van de Vivjer F, Holding P, Newton C. Paediatric HIV and neurodevelopment in sub-Saharan Africa: a systematic review. Trop Med Int Health 2008;13(7):1–8.
76. Tardieu M, Mayaux M, Seibel N, Funck-Brentano I, Straub E, Teglas J, et al. Cognitive assessment of school-age children infected with maternally transmitted human immunodeficiency virus type-1. J Pediatr 1995;126:375–9.
77. Patel K, Ming X, Williams P, Robertson K, Oleske J, Seage G. Impact of HAART and CNS-penetrating antiretroviral regimens on HIV encephalopathy among perinatally infected children and adolescents. AIDS 2009;23:1–9.
78. de Luca A, Ciancio B, Larussa D, Murri R, Cingolani A, Rizzo M, et al. Correlates ofindependent HIV-1 replication in the CNS and of its control by antiretrovirals. Neurology 2002;59:342–7.
79. Cysique L, Maruff P, Brew B. Antiretroviral therapy in HIV infection: are neurologically active drugs important? Arch Neurol 2004;61:1699–704.
80. van Dyke R, Wang L, Williams P. Toxicities associated with dual nucleoside reverse transcriptase inhibitor regimens in HIV-infected children. J Infect Dis 2008;198:1599–608.
81. Soh C, Oleske J, Brady M, Spector S, Borkowsky W, Burchett S, et al. Long-term effects ofprotease-inhibitor-based combination therapy on CD4 T-cell recovery in HIV-1-infected children and adolescents. Lancet 2003;362:2045–51.
82. Reddi A, Leeper S, Grobler A, Geddes R, France H, Dorse G, et al. Preliminary outcomes of a paediatric highly active antiretroviral therapy cohort from KwaZulu-Natal, South Africa. BMC Pediatr 2007;7:13.
83. Resino S, Resino R, Micheloud D, Gutie D, Antonio J, Ramos J, et al. Long-term effects ofhighly active antiretroviral therapy in pretreated, vertically HIV type 1-infected children: 6 years of follow-up. Clin Infect Dis 2006;42:862–9.
84. Cowburn C, Hatherill M, Eley B, Nuttall J, Hussey G, Reynolds L, et al. Short-term mortality and implementation of antiretroviral treatment for critically Ill HIV-infected children in a developing country. Arch Dis Child 2007;92:234–41.
85. Feucht U, Kinzer M, Kruger M. Reasons for delay in initiation ofantiretroviral therapy in a population ofHIV-infected South African children. J Trop Pediatr 2007;53(6):398–402.
86. Kim J, Gilks C. Scaling up treatment–why we can’t wait. N Engl J Med 2005;353(22):2392–4.
87. Harries A, Nyangulu D, Hargreaves N, Kaluwa O, Salaniponi F. Preventing antiretroviral anarchy in sub-Saharan Africa. Lancet 2001;358:410–4.
88. Sutcliffe C, van Dijk J, Bolton C, Persaud D, Moss W. Effectiveness of antiretroviral therapy among HIV-Infected children in sub-Saharan Africa. Lancet 2008;8:477–489.
89. Heller L. Nutrition support for children with HIV/AIDS. J Am Diet Assoc 1997;97:473–4.